Treatment of Post-Punch Biopsy Bleeding in Apixaban-Treated Patients Using Self-Administered BXP154B
Clinical trial NCT06205615 · COMPLETED
Trial details
- NCT number
- NCT06205615
- Sponsor
- Bio 54, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-24
- Primary completion
- 2024-03-14
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.